Key Development UK-based biopharmaceutical firm Mereo BioPharma and Sentynl Therapeutics (a rare disease commercial subsidiary of Indian pharmaceutical group Zydus... Read more
Category: Uncategorized
Food Safety Governance: Acting US FDA Commissioner Reaffirms Consumer Confidence in Fresh Produce, Releasing Updated Ready-to-Eat Processed Produce Guidance
Key Development In a televised appearance on CNBC on August 11, 2026, Acting U.S. FDA Commissioner Kyle Diamantas reassured the... Read more
Emergency Medical Services Modernization: Vietnam Issues Prime Ministerial Decision 1515/QD-TTg Approving National Pre-Hospital Emergency Care Development Plan 2026–2030, Integrating 113–114–115 Command Infrastructure
Key Development On August 10, 2026, Deputy Prime Minister Pham Thi Thanh Tra, acting on behalf of the Prime Minister,... Read more
Primary Healthcare Coverage Expansion: Ministry of Health Plans to Expand VHI Reimbursement for Nearly 350 Drugs at Commune Health Stations
Key Development In response to voter inquiries regarding the limited availability of insured pharmaceuticals at primary healthcare facilities, Minister of... Read more
Municipal Healthcare Regulatory Enforcement: Hai Phong Identifies 302 Unlicensed Medical Facilities, Mandating National Data Digitization by August 31, 2026
Key Development The Hai Phong Department of Health has officially released the results of a comprehensive municipal healthcare audit, identifying... Read more
Regional Healthcare Export Modernization: Ministry of Health Releases Draft Medical Tourism Master Plan 2026–2030, Targeting 750,000 International Patients and $2.5 Billion Revenue
Key Development This morning, August 12, 2026, the Ministry of Health (MOH) of Vietnam formally initiated public and stakeholder consultations... Read more
Vulnerable Healthcare Infrastructure Expansion: Ho Chi Minh City Plans New 2,000-Bed Psychiatric Hospital and Rehabilitation Complex, Directing Emergency Relocation of Pediatric Care Units
Key Development On the morning of August 11, 2026, a delegation from the Ho Chi Minh City Party Committee led... Read more
Expanding Ophthalmic Biosimilar Footprint: Samsung Bioepis Officially Launches Opuviz® (Aflibercept Biosimilar) Pre-Filled Syringe Across Europe
Key Development South Korean biopharmaceutical major Samsung Bioepis Co., Ltd. officially announced the commercial availability of the pre-filled syringe (PFS)... Read more
Domestic Biomanufacturing Infrastructure Expansion: Bristol Myers Squibb Selects Houston’s Generation Park for $2.3 Billion Multi-Modal Manufacturing Campus
Key Development Biopharmaceutical major Bristol Myers Squibb (NYSE: BMY) has officially selected Generation Park in Houston, Texas, as the site... Read more









